Open access · CC-BY
via OpenAlex
Frailty and Rejuvenation with Stem Cells: Therapeutic Opportunities and Clinical Challenges
Xuelian Sun, Qiukui Hao, Ren-Jie Tang, Chun Xiao, Meiling Ge, Birong Dong
Rejuvenation Research · 2019 · ▲ 22 citations
Cellular senescence
Stem-cell exhaustion
Chronic inflammation
Stem-cell therapy
Human
Systematic review
Preclinical / animal
Review
Abstract
Frailty, one appealing target for improving successful aging of the elderly population, is a common clinical syndrome based on the accumulation of multisystemic function declines and the increase in susceptibility to stressors during biological aging. The age-dependent senescence(definition), the frailty-related stem cell depletion, chronic inflammation, imbalance of immune homeostasis, and the reduction of multipotent stem cells collectively suggest the rational hypothesis that it is possible to (partially) cure frailty with stem cells. This systematic review has included all of the human trials of stem cell therapy for frailty from the main electronic databases and printed materials and screened the closely related reviews themed on the mechanisms of aging, frailty, and stem cells, to provide more insights in stem cell strategies for frailty, one promising method to recover health from a frail status. To date, a total of four trials about this subject have been registered on clinicaltrials.gov. The use of mesenchymal stem cells (MSCs), doses of 100 million cells, single peripheral intravenous infusion, follow-up periods of 6-12 months, and a focus primarily on safety and secondarily on efficacy are common characteristics of these studies. We conclude that intravenous infusion of allogenic MSCs is safe, well tolerated, and preliminarily effective clinically. More preclinical experiments and clinical trials are warranted to precisely elucidate the mechanism, safety, and efficacy of frailty stem cell therapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1089/rej.2017.2048
- Canonical
- link ↗
- Fetched
- 2026-10-24 MST
Cite this
APA
Sun, X., Hao, Q., Tang, R., Xiao, C., Ge, M., & Dong, B. (2019). Frailty and Rejuvenation with Stem Cells: Therapeutic Opportunities and Clinical Challenges. <em>Rejuvenation Research</em>. https://doi.org/10.1089/rej.2017.2048
Vancouver
Sun X, Hao Q, Tang R, Xiao C, Ge M, Dong B. Frailty and Rejuvenation with Stem Cells: Therapeutic Opportunities and Clinical Challenges. Rejuvenation Research. 2019. doi:10.1089/rej.2017.2048.
BibTeX
@article{xuelian2019Frailt,
title = {Frailty and Rejuvenation with Stem Cells: Therapeutic Opportunities and Clinical Challenges},
author = {Xuelian Sun and Qiukui Hao and Ren-Jie Tang and Chun Xiao and Meiling Ge and Birong Dong},
journal = {Rejuvenation Research},
year = {2019},
doi = {10.1089/rej.2017.2048},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Foundation for Orthopaedics and Regenerative Medicine 2022
Open access · US-GOV
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Aging Frailty
VA Office of Research and Development 2023
Open access · US-GOV
A Pilot Study of Mesenchymal Stem Cells as Novel Therapy for Age-Related Frailty in Veterans
Mechanisms of Ageing and Development 2019
Citation only
Attenuation of frailty in older adults with mesenchymal stem cells
International Journal of Molecular Sciences 2019
Open access · CC-BY
Mesenchymal Stem Cells in Homeostasis and Systemic Diseases: Hypothesis, Evidences, and Therapeutic Opportunities
Revista da Associação Médica Brasileira 2020
Open access · CC-BY
Mesenchymal stem cell therapy in acute kidney injury (AKI): review and perspectives
2020
Citation only